Ibotta, Inc.
NYSE:IBTASoftware - Application
-$0.19 today
- Market cap
- $1.14B
- Beta
- -0.58
- P/E (TTM)
- -96.1
- EPS (TTM)
- -$0.30
Volume 0.31M
Average 0.22M
IBTA Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Ibotta, Inc.NYSE: IBTA
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $2.87M rose 32.6% year over year, ahead of the +8.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 16.4% from the prior quarter. Over 3 fiscal years it compounded at +9.6% a year.
Context
- Depreciation & amortization amounted to 2.4% of revenue in FY2025, up 0.2 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +32.6% holds above the trailing-twelve-month pace of +8.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 8.32M USD
- Year-over-year change
- +3.0%
- 3-year CAGR
- +9.6%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.32M | +3.0% |
| FY2024 | 2024-12-31 | 8.08M | +21.2% |
| FY2023 | 2023-12-31 | 6.66M | +5.5% |
| FY2022 | 2022-12-31 | 6.32M | — |
Depreciation & Amortization vs competitors
How IBTA compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +8.3% is the 6th highest of 10, against a peer median of +11.1%.
- Depreciation & amortization amounts to 2.7% of revenue for IBTA, versus a peer median of 1.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CN¥93.51M CNY | +79.6% | +4.2% | 0.7% | |
| LTM Mar 2026 | $71.45M USD | -16.4% | -5.2% | 12.6% | |
| LTM Mar 2026 | $10.93M USD | +11.1% | +16.9% | 11.6% | |
| LTM Mar 2026 | $9.03M USD | +8.3% | +9.6% | 2.7% | |
| LTM Mar 2026 | $6.58M USD | +43.8% | -6.0% | 1.9% | |
| LTM Mar 2026 | $5.7M USD | +32.4% | -35.8% | 4.5% | |
| LTM Mar 2026 | $4.3M USD | +27.7% | +11.6% | 1.7% | |
| LTM Mar 2026 | $3.99M USD | -53.9% | -27.6% | 0.7% | |
| LTM Mar 2026 | $3.41M USD | -14.5% | -10.9% | 1.4% | |
| LTM Mar 2026 | $234K USD | -103.7% | +2.7% | 0.2% | |
| Peer median (excluding IBTA) | — | +11.1% | -5.2% | 1.7% | |
Competitors are the stored peer set for IBTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | (54.86M) | 38.12M | 68.74M | 3.58M |
| Depreciation & Amortization | 6.32M | 6.66M | 8.08M | 8.32M |
| Deferred Income Tax | 0 | 0 | 0 | 3.15M |
| Stock-Based Compensation | 6.5M | 6.99M | 46.92M | 44.14M |
| Change in Working Capital | (26.78M) | (51.6M) | (52.76M) | 24.67M |
| Accounts Receivables | (34.51M) | (105.71M) | 4.4M | 10.24M |
| Inventory | 0 | 0 | 0 | 0 |
| Accounts Payables | (4.53M) | 1.82M | (911K) | 355K |
| Other Working Capital | 12.26M | 52.29M | (56.25M) | 14.07M |
| Other Non-Cash Items | 12.32M | 22.55M | 44.94M | 11.42M |
| Operating Cash Flow | (56.5M) | 22.72M | 115.92M | 95.27M |
| Capital Expenditures | (8.26M) | (8.23M) | (10.2M) | (20.29M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (65.98M) | 0 | 0 | 0 |
| Sales of Investments | 38.57M | 27.9M | 0 | 0 |
| Other Investing Activities | (7.48M) | (7.68M) | (9.33M) | (14.01M) |
| Investing Cash Flow | (35.68M) | 19.67M | (10.2M) | (34.3M) |
| Debt Repayment | 73.33M | 0 | 0 | 0 |
| Common Stock Issued | 76.12M | 2.4M | 206.69M | 12.34M |
| Common Stock Repurchased | 0 | 0 | (31.32M) | (232.97M) |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | (75.41M) | (12K) | 6.01M | (3.42M) |
| Financing Cash Flow | 74.05M | 2.39M | 181.38M | (224.05M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | (18.13M) | 44.77M | 287.1M | (163.08M) |
| Free Cash Flow | (64.76M) | 14.49M | 105.72M | 74.98M |
Ibotta, Inc.
NYSE:IBTA
Intrinsic Alpha fair value
Locked
Current Price
$55.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.